GlassScriptPhysician profile
Julia Nieto
NPI 1669920732
$3,332.65
in general payments reported to CMS, 2019-2025
25 companies · $827 in 2025
The $827 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $345 · 2022: $506 · 2023: $714 · 2024: $941 · 2025: $827.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,481.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $997.51 | 2022-2025 | Breztri, Airsupra, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $709.90 | 2021-2025 | Jardiance |
| Lilly USA, LLC | $198.29 | 2021-2024 | Mounjaro, Jardiance |
| Glaxosmithkline, LLC. | $190.63 | 2021-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Amgen INC. | $133.52 | 2024-2025 | Krystexxa, Otezla, Repatha |
| Merck Sharp & Dohme LLC | $121.20 | 2022-2024 | Steglatro, Belsomra, Capvaxive |
| Exact Sciences Corporation | $120.97 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $108.59 | 2021-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $105.60 | 2024-2025 | |
| Abbott Laboratories | $91.29 | 2022-2025 | Freestyle Libre 3, Proclaim |
| Novo Nordisk INC | $86.65 | 2023-2025 | Rybelsus, Ozempic |
| Lucid Diagnostics INC. | $79.22 | 2022-2023 | |
| Shield Therapeutics INC | $57.15 | 2022-2024 | Accrufer |
| Amarin Pharma, INC. | $52.90 | 2021 | |
| Boston Scientific Corporation | $41.16 | 2022-2023 | Superion Indirect Decompression System |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $39.49 | 2022-2024 | |
| Gilead Sciences, INC. | $36.64 | 2025 | Yeztugo |
| Horizon Therapeutics Plc | $28.03 | 2021 | |
| Medtronic, INC. | $24.09 | 2023 | Intellis Adaptivestim |
| Redhill Biopharma INC. | $20.81 | 2022 | |
| Corcept Therapeutics | $19.22 | 2025 | Korlym |
| Cranial Technologies, INC | $18.37 | 2024 | Doc Band |
| Astellas Pharma US INC | $18.14 | 2024 | Veozah |
| Intra-Sana Laboratories | $17.54 | 2024 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Cequr Corporation | $15.74 | 2024 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Nieto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.